US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.
US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.
<iframe src="https://hindustansphere.com/embed/cluster/8bc9d6b727fc1bdbc03b6c8d956624657f792521" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Approval of India-made HIV-prevention shot raises hopes in poorer nations"></iframe>
